PALX
Palomino Laboratories Inc.Company Information
- Company Name
- Palomino Laboratories Inc.
- CIK
- CIK0001938569
- Category
- <br>Emerging growth company
- Ticker: Exchange
- PALX: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 04 Manufacturing
- SIC
- 3674
- SIC Description
- Semiconductors & Related Devices
- Ticker
- PALX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-04-20
- Last sale
- —
- Shares purchased (TTM)
- 25,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 22.85%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 19 | 7 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Assets Current | 20 | 7 | 8 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 1 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Costs | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 21 | 7 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | - | - | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Convertible Notes Payable Current | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Accrued Liabilities And Other Liabilities | 0 | 0 | 0 | 1 | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | - | - | - | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 26 | 11 | 11 | 10 | - | - | -0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -6 | -4 | -3 | -2 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | 21 | 7 | 8 | 7 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 21 | 7 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 50 | 50 | 300 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 23 | 19 | 19 | 18 | 2 | 2 | 5 | 2 | 2 | 2 | 2 | 2 | ||||||
| Shares Outstanding | 23 | 19 | 19 | 18 | 2 | 2 | 5 | 2 | 2 | 2 | 2 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPalomino Laboratories Inc. (PALX) — SEC Financial Statements & Analysis
Palomino Laboratories Inc. (PALX) is a semiconductors & related devices company, incorporated in DE. Palomino Laboratories Inc. trades on OTC as: PALX. Palomino Laboratories Inc. (PALX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, On profitability, Palomino Laboratories Inc. posts a Return on Equity (ROE) of -51.45%, a Return on Assets (ROA) of -49.19%, and a Return on Invested Capital (ROIC) of -66.91%. Per share, it reports EPS of $-0.24, diluted EPS of $-0.24, free cash flow per share of $-0.22, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 878.70% year-over-year and EPS growth of 15.92% year-over-year. On the balance sheet, it maintains a current ratio of 53.12x, a quick ratio of 52.71x, working capital of $19.22M, a debt-to-equity ratio of 0.02x, a debt ratio of 0.02, an interest coverage ratio of -477.53x, free cash flow of $-4.70M (TTM), and net debt of $-19.44M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.24
- ROE TTM
- -51.45%
- ROA TTM
- -49.19%
- Debt To Equity
- 0.02x
- Free Cash Flow TTM
- $-4.70M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Palomino Laboratories Inc. in?
Palomino Laboratories Inc. (PALX) operates in the Semiconductors & Related Devices industry.
What exchange does PALX trade on?
Palomino Laboratories Inc. (PALX) trades on the OTC.
Where is Palomino Laboratories Inc. incorporated?
Palomino Laboratories Inc. is incorporated in DE.
When was Palomino Laboratories Inc. (PALX)'s most recent SEC filing?
Palomino Laboratories Inc. (PALX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is PALX's EPS (earnings per share)?
Palomino Laboratories Inc. (PALX)'s trailing twelve month EPS is $-0.24 as of 2026-06-30.
What is PALX's ROE (return on equity)?
Palomino Laboratories Inc. (PALX)'s trailing twelve month Return on Equity (ROE) is -51.45% as of 2026-06-30.
What is PALX's ROA (return on assets)?
Palomino Laboratories Inc. (PALX)'s trailing twelve month Return on Assets (ROA) is -49.19% as of 2026-06-30.
What is PALX's ROIC (return on invested capital)?
Palomino Laboratories Inc. (PALX)'s trailing twelve month Return on Invested Capital (ROIC) is -66.91% as of 2025-12-31.

